Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

actavis new zealand limited - carvedilol 25mg - tablet - 25 mg - active: carvedilol 25mg excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate povidone sucrose

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

actavis new zealand limited - carvedilol 3.125mg - tablet - 3.125 mg - active: carvedilol 3.125mg excipient: colloidal silicon dioxide crospovidone iron oxide red lactose monohydrate magnesium stearate povidone sucrose

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

actavis new zealand limited - carvedilol 6.25mg - tablet - 6.25 mg - active: carvedilol 6.25mg excipient: colloidal silicon dioxide crospovidone iron oxide yellow lactose monohydrate magnesium stearate povidone sucrose

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

actavis new zealand limited - gliclazide 80mg - tablet - 80 mg - active: gliclazide 80mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate pregelatinised maize starch purified talc purified water

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - atenolol 100mg - tablet - 100 mg - active: atenolol 100mg excipient: gelatin heavy magnesium carbonate magnesium stearate maize starch microcrystalline cellulose purified talc sodium laurilsulfate - management of hypertension

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - atenolol 25mg - tablet - 25 mg - active: atenolol 25mg excipient: gelatin heavy magnesium carbonate magnesium stearate maize starch microcrystalline cellulose purified talc sodium laurilsulfate - management of hypertension

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - atenolol 50mg - tablet - 50 mg - active: atenolol 50mg excipient: gelatin heavy magnesium carbonate magnesium stearate maize starch microcrystalline cellulose purified talc sodium laurilsulfate - management of hypertension

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - ceftriaxone sodium 1.193 g (present as 1.193g ceftriaxone na*3.5h2o. eq 1.0793g of ceftriaxone na anhyd or 1g ceftriaxone anhyd);  ;   - powder for injection - 1 g - active: ceftriaxone sodium 1.193 g (present as 1.193g ceftriaxone na*3.5h2o. eq 1.0793g of ceftriaxone na anhyd or 1g ceftriaxone anhyd)    

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - ceftriaxone sodium 2.386 g (present as 2.386g ceftriaxone na*3.5h2o. eq 2.158g of ceftriaxone na anhyd or 2g ceftriaxone anhyd);  ;   - powder for injection - 2 g - active: ceftriaxone sodium 2.386 g (present as 2.386g ceftriaxone na*3.5h2o. eq 2.158g of ceftriaxone na anhyd or 2g ceftriaxone anhyd)    

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - losartan potassium 12.5mg;   - film coated tablet - 12.5 mg - active: losartan potassium 12.5mg   excipient: colloidal silicon dioxide hypromellose indigo carmine macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   sodium starch glycolate titanium dioxide - indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.